Reiko Watanabe

2.5k citations
59 papers · 1.0k indexed · h-index 19
Topics
Lung Cancer Research Studies (11 papers)Neuroendocrine Tumor Research Advances (7 papers)Glioma Diagnosis and Treatment (6 papers)

In The Last Decade

Reiko Watanabe

56 papers receiving 981 citations

Peers

Reiko Watanabe
Comparison fields: 5 of 78
  • Oncology 473
  • Pulmonary and Respiratory Medicine 252
  • Epidemiology 220
  • Molecular Biology 217
  • Genetics 141
Replace Zahid Kaleem with:
Zahid Kaleem United States
Malte Kircher Germany
Jonathan Keith Killian United States
Hyun Jung Jun South Korea
José María Sayagués Spain
Francesco Pierconti Italy
Maria Raffaella Ambrosio Italy
Jau‐Yu Liau Taiwan
Eble Jn United States
Craig J. Reist United States
Reiko Watanabe relative to Zahid Kaleem United States Zahid Kaleem's profile →
Citations per field
00.5×6.2×
Zahid Kaleem · 1×
Citations per year

Countries citing papers authored by Reiko Watanabe

Since Specialization
Citations

This map shows the geographic impact of Reiko Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiko Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiko Watanabe more than expected).

Fields of papers citing papers by Reiko Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reiko Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiko Watanabe. The network helps show where Reiko Watanabe may publish in the future.

Co-authorship network of co-authors of Reiko Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Reiko Watanabe. A scholar is included among the top collaborators of Reiko Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiko Watanabe. Reiko Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 1
4 5
5 2
6 9
7 9
8 10
9 80
10 0
11 73
12 6
13 7
14 18
15 15
16 30
17 20
18 13
19 26
20 4

About Reiko Watanabe

Reiko Watanabe is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (11 papers), Neuroendocrine Tumor Research Advances (7 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (473 citations), Genetics (141 citations) and Neurology (118 citations). Reiko Watanabe has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Ichiro Ito, Yoko Nakasu, Toru Kameya, Koichi Mitsuya, Tsuneo Imai, Toyone Kikumori, Haruyasu Murakami, Tateaki Naito, Masahiro Endo and Toshiaki Takahashi. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026